Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A

Project Information

HemAcure

Grant agreement ID: 667421

DOI 10.3030/667421

Project closed

EC signature date 9 December 2015

Start date 1 November 2015

End date 31 October 2018

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 5 564 395,00

EU contribution € 5 564 395,00

Coordinated by

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT
Germany

Deliverables

Documents, reports (2)

Exploitation activity (as above)
Individualized press release for every partner

Other (1)

Final dissemination activity on project results

Websites, patent fillings, videos etc. (1)

Launch of website, Twitter, Facebook, LinkedIn etc.

Publications

Other (1)

Combined ATMPs Containing Genetically Modified Cells

Author(s): Patrick Bittorf, Martin Zierau, Ralf Sanzenbacher, Heike Walles, Joris Braspenning
Published in: Pharmazeutische Medizin, 2017, Page(s) 168-174
Publisher: DeGePe GmbH

Thesis and dissertations (2)

"""Use of BOECs for therapeutic applications"""

Author(s): Miguel Rodrigues
Published in: 2018
Publisher: University of Wuerzburg

Genetically modified cells for treatment of heamophilia A

Author(s): Patrick Bittorf
Published in: 2019
Publisher: University Würuburg

Conference proceedings (4)

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A

Author(s): Chiara Borsotti, Simone Merlin, Cristina Olgasi, Thorsten Bergmann, Delfina M. Mazzuca, Alexandra Stolzing, Martin Zierau, Philip M. Toleikis, Joris Braspenning and Antonia Follenzi
Published in: Blood Transfusion, Issue Vol.15, Supplement No. 3, September 2017, 2017, Page(s) s483, ISSN 1723-2007
Publisher: Edizioni SIMTI

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A

Author(s): C Olgasi, S Merlin, C Borsotti, T Bergmann, D M Mazzucca, A Stolzing, M Zierau, P M Toleikis, J Braspenning, A Follenzi  
Published in: ESGCT abstract book 2018, Issue 16th-19th October 2018, 2018
Publisher: ESGCT

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A (poster presentation at ESGCT congress, Berlin, 2017)

Author(s): Cristina Olgasi, Simone Merlin, Thorsten Bergmann, Chiara Borsotti, Delfina M. Mazzuca, Alexandra Stolzing, Martin Zierau, Philip M. Toleikis, Joris Braspenning and Antonia Follenzi
Published in: Human Gene Therapy, Issue Vol.28, No. 12, 1st December 2017, 2017, Page(s) pp A92, ISSN 1043-0342
Publisher: Mary Ann Liebert

Advancing Tissue and Regenerative Engineering in UK Medicine (ATREUM) abstracts booklet

Author(s): Harrison, Richard P., Adams, Christopher F.
Published in: 2017, ISBN 978-0-9955941-0-4
Publisher: University Loughborough